2008 News First Major Medical Meeting Convening for MRI-Guided Focused Ultrasound to Treat Cancer, Stroke, Fibroids, Other Conditions August 26, 2008 First U.S. Patient Undergoes Non-Invasive Magnetic Resonance-Guided Focused Ultrasound Procedure to Relieve Pain from Bone Metastases Experimental procedure performed as part of a large U.S. clinical trial, July 21, 2008 FDA Clears ExAblate Fertility Enhancement Study in Women with Uterine Fibroids Study will compare Birth Rates of Women who Underwent Non-Invasive MRgFUS to those who had Invasive Fibroid Surgery, May 28, 2008 Foundation promotes use of technology combining magnetic resonance, ultrasound Virginia News, Business Trends, May 2008, May 18, 2008 InSightec to Exhibit Non-Invasive Treatment for Uterine Fibroids at 5th Annual World Health Care Congress MR guided Focused Ultrasound Surgery Advances Women’s Health and Wellness, Reduces Healthcare Costs, April 21, 2008 Published in BJOG: International Journal of Obstetrics and Gynecology - Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids March 13, 2008 InSightec submitted the sixth semi-annual report of results to date In October 2004, the FDA approved the ExAblate®2000 system for the treatment of uterine fibroids. A requirement of the approval was continued follow-up of a group of patients for 36 months. In December, 2007, InSightec submitted the sixth semi-annual report of results to date. This document is a summary of that report., April 08, 2008